|
|
|
|
|
|
|
CRISPR Therapeutics AG (CRSP)
|
|
61.3 -1.48 (-2.36%)
|
06-25 15:28
|
|
Open:
|
62.8
|
Pre. Close:
|
62.78
|
|
High:
|
63.408
|
Low:
|
60.28
|
|
Volume:
|
778,227
|
Market Cap:
|
2893M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
65.128 - 65.535
|
65.535 - 65.822
|
|
Low:
|
61.548 - 62.049
|
62.049 - 62.402
|
|
Close:
|
62.125 - 62.855
|
62.855 - 63.37
|
|
|
|
Technical analysis (as of: 2018-06-25 2:16:41 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 77.24 One year: 86.32
|
|
Support:
|
Support1: 53.56 Support2: 44.56
|
|
Resistance:
|
Resistance1:
66.13 Resistance2: 73.90
|
|
Pivot:
|
62.94
|
|
Moving Averages:
|
MA(5): 63.45 MA(20): 64.43
MA(100): 52.58  MA(250): 33.24
|
|
MACD:
|
MACD(12,26):
0.62 Signal(12,26,9): 1.12
|
|
%K %D:
|
%K(14,3): 57.81 %D(3): 59.79
|
|
RSI:
|
RSI(14): 49.67
|
|
52-Week:
|
High: 73.9
Low: 15.55 Change(%): 258.3
|
|
Average Vol(K):
|
3-Month: 164849
10-Days 160429
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.CRSP has closed above bottom band by 43.5%. Bollinger Bands are 10.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-06-25T12:24:52-04:00
Genomic Medicine: Is The Platform The FDA Product?
2018-06-25T06:11:58-04:00
Gilead Sciences Is Too Cheap To Ignore - Cramer's Lightning Round (6/22/18)
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
